Literature DB >> 8396370

Barbiturate-benzodiazepine interactions at the gamma-aminobutyric acidA receptor in rat cerebral cortical synaptoneurosomes.

T M DeLorey1, I Kissin, P Brown, G B Brown.   

Abstract

Combinations of benzodiazepines (midazolam and diazepam) with barbiturates (pentobarbital and phenobarbital) exhibit synergistic (supra-additive) hypnotic interactions in rats. Because both benzodiazepines and barbiturates interact with the gamma-aminobutyric acidA (GABAA) receptor complex, we have tested the hypothesis that these supra-additive hypnotic interactions are due to a synergistic effect on Cl- conductance subsequent to binding at allosterically coupled sites on the GABAA receptor ionophore complex. Equilibrium binding and 36Cl- flux measurements were performed under nearly identical conditions using rat brain cerebrocortical synaptoneurosomes. The benzodiazepines and barbiturates alone both allosterically enhance binding of [3H]muscimol to comparable, but modest, extents (range = 18%-32% enhancement). Isobolographic analysis reveals that combinations of benzodiazepines and barbiturates do in fact produce a synergistic enhancement of [3H]muscimol binding. Paradoxically, this effect is not translated into a synergistic enhancement of muscimol-stimulated 36Cl- flux. Because the positively cooperative interactions between benzodiazepines and barbiturates, as demonstrated both behaviorally and by binding measurements, are not reflected in enhanced Cl- conductance, the mechanistic basis for hypnotic synergism may involve other non-GABAergic components.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396370     DOI: 10.1213/00000539-199309000-00030

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  7 in total

1.  Optimal dose of thiamylal in combination with midazolam for induction of anaesthesia.

Authors:  T Nishiyama; K Hanaoka
Journal:  Can J Anaesth       Date:  1996-11       Impact factor: 5.063

2.  The Actions of Drug Combinations on the GABAA Receptor Manifest as Curvilinear Isoboles of Additivity.

Authors:  Daniel J Shin; Allison L Germann; Joe Henry Steinbach; Gustav Akk
Journal:  Mol Pharmacol       Date:  2017-08-08       Impact factor: 4.436

3.  The neurosteroid 5β-pregnan-3α-ol-20-one enhances actions of etomidate as a positive allosteric modulator of α1β2γ2L GABAA receptors.

Authors:  P Li; J R Bracamontes; B D Manion; S Mennerick; J H Steinbach; A S Evers; G Akk
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

4.  Combined discriminative stimulus effects of midazolam with other positive GABAA modulators and GABAA receptor agonists in rhesus monkeys.

Authors:  Lance R McMahon; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2004-10-14       Impact factor: 4.530

5.  The sleep hormone oleamide modulates inhibitory ionotropic receptors in mammalian CNS in vitro.

Authors:  Leanne Coyne; George Lees; Russell A Nicholson; Jian Zheng; Katherine D Neufield
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

6.  Tetramethylenedisulfotetramine alters Ca²⁺ dynamics in cultured hippocampal neurons: mitigation by NMDA receptor blockade and GABA(A) receptor-positive modulation.

Authors:  Zhengyu Cao; Bruce D Hammock; Mark McCoy; Michael A Rogawski; Pamela J Lein; Isaac N Pessah
Journal:  Toxicol Sci       Date:  2012-08-13       Impact factor: 4.849

7.  Clinical evaluation of a combination therapy of imepitoin with phenobarbital in dogs with refractory idiopathic epilepsy.

Authors:  Jasmin Neßler; Chris Rundfeldt; Wolfgang Löscher; Draginja Kostic; Thomas Keefe; Andrea Tipold
Journal:  BMC Vet Res       Date:  2017-01-25       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.